{"log_id": 8481776178747763038, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 1e-05, "average": 0.997969, "min": 0.983609}, "location": {"width": 745, "top": 250, "height": 32, "left": 262}, "words": "大部分患者的致动脉粥样硬化指数不会升高,且使用降脂药物对总胆固醇升高进行治"}, {"probability": {"variance": 1e-06, "average": 0.998547, "min": 0.997037}, "location": {"width": 65, "top": 296, "height": 24, "left": 222}, "words": "疗有效"}, {"probability": {"variance": 2e-06, "average": 0.999128, "min": 0.993076}, "location": {"width": 745, "top": 330, "height": 30, "left": 263}, "words": "在全部对照和全部暴露人群中,血脂的升高方式和发生率与6个月对照试验数据一致"}, {"probability": {"variance": 0, "average": 0.999996, "min": 0.999996}, "location": {"width": 29, "top": 330, "height": 29, "left": 1147}, "words": "管"}, {"probability": {"variance": 1e-05, "average": 0.997674, "min": 0.991571}, "location": {"width": 103, "top": 375, "height": 23, "left": 265}, "words": "上市后经验"}, {"probability": {"variance": 3e-06, "average": 0.998843, "min": 0.992001}, "location": {"width": 745, "top": 409, "height": 30, "left": 264}, "words": "除报道使用托珠单抗治疗期间的致死性速发过敏反应以外,上市后治疗的安全性与临"}, {"probability": {"variance": 0, "average": 0.999222, "min": 0.999222}, "location": {"width": 30, "top": 408, "height": 28, "left": 1151}, "words": "章"}, {"probability": {"variance": 1.2e-05, "average": 0.997712, "min": 0.98722}, "location": {"width": 471, "top": 450, "height": 28, "left": 222}, "words": "床试验数据一致(见【注意事项】一般注意事项部分)"}, {"probability": {"variance": 0, "average": 0.999703, "min": 0.999029}, "location": {"width": 72, "top": 490, "height": 25, "left": 230}, "words": "【禁忌】"}, {"probability": {"variance": 1e-06, "average": 0.99883, "min": 0.996288}, "location": {"width": 460, "top": 528, "height": 26, "left": 265}, "words": "对托珠单抗或者对任何辅料发生超敏反应的患者禁用"}, {"probability": {"variance": 2e-06, "average": 0.999131, "min": 0.995546}, "location": {"width": 460, "top": 568, "height": 25, "left": 267}, "words": "感染活动期患者(参见【注意事项】一般事项:感染"}, {"probability": {"variance": 0, "average": 0.999742, "min": 0.999465}, "location": {"width": 107, "top": 609, "height": 26, "left": 236}, "words": "【注意事项】"}, {"probability": {"variance": 0, "average": 0.999573, "min": 0.999128}, "location": {"width": 85, "top": 648, "height": 24, "left": 266}, "words": "一般事项"}, {"probability": {"variance": 8e-06, "average": 0.997961, "min": 0.991309}, "location": {"width": 194, "top": 685, "height": 28, "left": 269}, "words": "感染(包括严重感染)"}, {"probability": {"variance": 0.000198, "average": 0.994452, "min": 0.924835}, "location": {"width": 745, "top": 721, "height": 31, "left": 267}, "words": "已有报道,接受免疫抑制剂(包括托珠单抗)治疗类风湿关节炎的患者发生了因细菌"}, {"probability": {"variance": 5e-06, "average": 0.998794, "min": 0.987656}, "location": {"width": 787, "top": 760, "height": 32, "left": 226}, "words": "分枝杆菌、侵袭性真菌、病毒、原虫或其他机会性病原体引起的严重感染,甚至致死性感"}, {"probability": {"variance": 8e-06, "average": 0.99884, "min": 0.985284}, "location": {"width": 786, "top": 800, "height": 30, "left": 226}, "words": "染。最常见的严重感染包括肺炎、尿道感染、蜂窝织炎、带状疱疹、胃肠炎、憩室炎、脓"}, {"probability": {"variance": 2e-06, "average": 0.998908, "min": 0.993757}, "location": {"width": 767, "top": 838, "height": 32, "left": 227}, "words": "毒症和细菌性关节炎。使用托珠单抗治疗发生的机会性感染包括结核菌、隐球菌、曲菌"}, {"probability": {"variance": 5e-06, "average": 0.998642, "min": 0.991146}, "location": {"width": 768, "top": 876, "height": 33, "left": 227}, "words": "念珠菌和肺孢子虫感染。临床试验中未报告的其他严重感染也可能发生(如组织胞浆菌"}, {"probability": {"variance": 6e-06, "average": 0.998283, "min": 0.988929}, "location": {"width": 787, "top": 916, "height": 32, "left": 227}, "words": "球孢子菌、李斯特菌感染)。患者表现为播散性而非局部感染,通常在合并使用免疫抑制"}, {"probability": {"variance": 1.7e-05, "average": 0.998137, "min": 0.978455}, "location": {"width": 737, "top": 955, "height": 33, "left": 228}, "words": "剂,如甲氨蝶呤或皮质类固醇,这类药物在治疗类风湿关节炎以外,还可使患者易感"}, {"probability": {"variance": 5e-05, "average": 0.995334, "min": 0.97023}, "location": {"width": 746, "top": 995, "height": 33, "left": 269}, "words": "对感染活动期(包括局部感染)患者不得给予托珠单抗。下列患者在开始托珠单抗治"}, {"probability": {"variance": 0, "average": 0.999254, "min": 0.998107}, "location": {"width": 226, "top": 1038, "height": 29, "left": 228}, "words": "疗前应进行利益风险评估"}, {"probability": {"variance": 1e-06, "average": 0.999545, "min": 0.997694}, "location": {"width": 163, "top": 1078, "height": 24, "left": 331}, "words": "慢性或复发性感染"}, {"probability": {"variance": 8e-06, "average": 0.998364, "min": 0.992286}, "location": {"width": 120, "top": 1117, "height": 25, "left": 331}, "words": "暴露于结核病"}, {"probability": {"variance": 0, "average": 0.999626, "min": 0.998231}, "location": {"width": 202, "top": 1156, "height": 25, "left": 332}, "words": "有严重或机会性感染史"}, {"probability": {"variance": 0.002489, "average": 0.982256, "min": 0.761084}, "location": {"width": 497, "top": 1194, "height": 33, "left": 273}, "words": "居住在或到地方性结核病或地方性真菌病地区旅行"}, {"probability": {"variance": 0.000664, "average": 0.991313, "min": 0.905916}, "location": {"width": 224, "top": 1234, "height": 26, "left": 334}, "words": "患有可使其易感的基础病。"}, {"probability": {"variance": 7e-06, "average": 0.998577, "min": 0.988162}, "location": {"width": 747, "top": 1270, "height": 31, "left": 273}, "words": "应密切监察患者在使用托珠单抗治疗期间和治疗后出现的感染症状和体征,因为急性"}, {"probability": {"variance": 4e-06, "average": 0.998775, "min": 0.988363}, "location": {"width": 787, "top": 1309, "height": 32, "left": 233}, "words": "炎症的症状和体征可因急性期反应物的抑制而减轻。如果有任何提示感染的症状出现,应"}, {"probability": {"variance": 0.006282, "average": 0.975607, "min": 0.593524}, "location": {"width": 684, "top": 1335, "height": 45, "left": 232}, "words": "指导患者立即与医生联系,以确保迅速评估并采取适当的治疗、份"}, {"probability": {"variance": 5.3e-05, "average": 0.997256, "min": 0.955631}, "location": {"width": 732, "top": 1386, "height": 33, "left": 276}, "words": "患者如发生严重感染、机会性感染或脓毒症,应中断托珠单抗治疗。对使用托珠单抗"}, {"probability": {"variance": 1.4e-05, "average": 0.997697, "min": 0.981384}, "location": {"width": 735, "top": 1425, "height": 34, "left": 236}, "words": "治疗期间的新发感染者应进行针对免疫系统受损患者的快速和全面诊断检查,应适当"}, {"probability": {"variance": 0.025917, "average": 0.864757, "min": 0.637395}, "location": {"width": 127, "top": 1418, "height": 43, "left": 975}, "words": "键股份"}, {"probability": {"variance": 1.6e-05, "average": 0.997316, "min": 0.987745}, "location": {"width": 283, "top": 1468, "height": 30, "left": 235}, "words": "抗菌药物治疗,并密切监察患者"}, {"probability": {"variance": 8e-06, "average": 0.998025, "min": 0.992084}, "location": {"width": 123, "top": 1509, "height": 25, "left": 280}, "words": "憩室炎并发症"}, {"probability": {"variance": 0, "average": 0.91038, "min": 0.91038}, "location": {"width": 68, "top": 1487, "height": 69, "left": 1005}, "words": "★"}], "language": 3}